Use of medication for enlarged prostate not associated with increased risk of hip fracture

Use of a class of medications for treating an enlarged prostate, known as 5-α reductase inhibitors, are not associated with an increased hip fracture risk, according to a study in the October 8 issue of JAMA.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news142616723.html">Use of medication for enlarged prostate not associated with increased risk of hip fracture</a></p> <p>Use of a class of medications for treating an enlarged prostate, known as 5-α reductase inhibitors, are not associated with an increased hip fracture risk, according to a study in the October 8 issue of <i>JAMA</i>.</p>